LncRNA miR503HG Regulates the Drug Resistance of Recurrent Cervical Squamous Cell Carcinoma Cells by Regulating miR-155/Caspase-3
Shanshan Zhao, Mingxin Yu, Lei Wang Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Gynaecology, Shenyang 110042, Liaoning Province, People’s Republic of ChinaCorrespondence: Mingxin YuCancer Hospital of China Medical University, Liaoning Cancer H...
Main Authors: | Zhao S, Yu M, Wang L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/lncrna-mir503hg-regulates-the-drug-resistance-of-recurrent-cervical-sq-peer-reviewed-article-CMAR |
Similar Items
-
LncRNA MIR503HG Promotes High-Glucose-Induced Proximal Tubular Cell Apoptosis by Targeting miR-503-5p/Bcl-2 Pathway
by: Cao X, et al.
Published: (2020-11-01) -
LncRNA miR503HG interacts with miR-31-5p through multiple ways to regulate cancer cell invasion and migration in ovarian cancer
by: Ding Zhu, et al.
Published: (2020-01-01) -
lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis
by: Shou-Man Wang, et al.
Published: (2021-06-01) -
The LncRNA MIR503HG/miR-224-5p/TUSC3 Signaling Cascade Suppresses Gastric Cancer Development via Modulating ATF6 Branch of Unfolded Protein Response
by: Han Lin, et al.
Published: (2021-07-01) -
LncRNA miR143HG Up-Regulates p53 In Endometrial Carcinoma By Sponging miR-125a
by: Shi F, et al.
Published: (2019-12-01)